Memorial Sloan Kettering Cancer Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Memorial Sloan Kettering Cancer Center sits in the top decile of US sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count).
Memorial Sloan Kettering Cancer Center: 1,884 sponsored US clinical trials, 327 recruiting.
Memorial Sloan Kettering Cancer Center sponsors 1,884 registered US clinical trials on ClinicalTrials.gov, 327 of them currently recruiting, and 1,104 completed. 75 of these trials are in Phase 3-4 (later-stage) and 1,101 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 98 trials.
Top-decile sponsor footprint
Memorial Sloan Kettering Cancer Center ranks in the top decile of sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,884 total, page 15 of 38
In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin
NCT00588315
A Model for Genetic Susceptibility: Melanoma
NCT00591500
Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer
NCT00588029
Menstrual Cycle Maintenance and Quality of Life: A Prospective Study
NCT00589654
Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors
NCT00580385
Clinical Significance of Germline BRCA Mutations
NCT00579488
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
NCT00579163
Molecular Studies and Clinical Correlations in Human Prostatic Disease
NCT00578240
A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
NCT07691489
A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma
NCT07650266
A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
NCT07414992
A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
NCT07313852
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
NCT06941480
A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)
NCT06333678
A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer
NCT05966584
A Study of XmAb23104 in People With Sarcoma
NCT05879185
A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma
NCT05788289
Virtual Mind-Body Exercises for People Having Pancreatic Surgery
NCT05431556
A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)
NCT05429320
A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor
NCT05275426
Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer
NCT05255393
A Study Comparing Geriatric Co-Management With Geriatric Guided Supportive Care in Older Patients Receiving Chemoradiation Therapy for Their Head and Neck Cancer
NCT05239000
Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer with Homologous Recombination Deficiency That Has Spread to the Liver
NCT05182112
A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer
NCT05190770
Registry to Collect Health Information Related to Fibrolamellar Cancer
NCT04874519
A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance
NCT05102370
Fluorescent Imaging of Nerves With Illuminare-1 During Surgery
NCT04983862
A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)
NCT04965090
A Study of Pembrolizumab and Cryoablation in People With Mesothelioma
NCT05071014
A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer
NCT05054374
A Study of E7820 in People With Bone Marrow (Myeloid) Cancers
NCT05024994
Study of a New Technique for Imaging Pancreatic Cancer
NCT04883775
Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19
NCT04824443
Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer
NCT04761055
Study of the Nevisense Device to Assess Atypical Skin Lesions
NCT04705168
A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors
NCT04671901
89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)
NCT04566978
Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma
NCT04552990
ZW25 in Women With Endometrial Cancers
NCT04513665
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection
NCT04510285
Communication Training for Cancer Patients, Their Caregivers, and Their Doctors
NCT04479605
Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
NCT04478123
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
NCT04462471
A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer
NCT04459650
Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy
NCT04401774
Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT04384146
A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy
NCT04381988
Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection
NCT04377659
Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors
NCT04343573
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer
NCT04337970
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 461 |
| Phase 2 | 640 |
| Phase 3 | 67 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Memorial Sloan Kettering Cancer Center pipeline
327 recruiting of 1,884 indexed (17% open); 1,104 completed (59%).
Phase mix: 75 late (III/IV) vs 1,101 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (98 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.